Literature DB >> 32394013

The Diagnostic Utility of Splenectomy in Idiopathic Splenomegaly.

Robert Naples1, Alexander Bertke1, Aldo Fafaj1, Samuel J Zolin1, Jonah D Thomas1, Clayton Petro1, David Krpata1, Ajita S Prabhu1, Michael J Rosen1, Steven Rosenblatt2.   

Abstract

INTRODUCTION: With increasing frequency, patients with idiopathic splenomegaly are referred to surgeons for splenectomy. We evaluated the diagnostic utility of splenectomy and feasibility of a minimally invasive approach in the face of idiopathic splenomegaly.
METHODS: We retrospectively reviewed 68 patients who underwent splenectomy for idiopathic splenomegaly. The primary endpoint was the rate of definitive diagnosis based on final surgical pathology of the removed spleen.
RESULTS: Preoperative workup included a bone marrow biopsy and peripheral blood smear in 93% and 100% of patients, respectively, with none having lymphadenopathy warranting biopsy. Splenectomy provided a definitive diagnosis for 44 (64.7%) patients. Of these, 34 (50%) patients had an underlying malignancy, of which more than half were splenic marginal zone lymphoma. There were 33 (48.5%) laparoscopic, 23 (33.8%) open, 10 (14.7%) laparoscopic converted to open, and two (2.9%) laparoscopic hand-assist cases. Conversion to open was due to splenic size [median craniocaudal length 21.8 cm (cm)] in eight and staple line bleeding at the splenic hilum in two patients. Overall, the laparoscopic approach was completed in patients with a smaller splenic size compared to open (median craniocaudal length 15.2 vs. 26.0 cm, p < 0.0001). The open group had one (1.5%) intra-operative mortality due to uncontrollable hemorrhage. Thirty-day complication rates were similar for laparoscopic and open approaches (p = 0.10).
CONCLUSION: Splenectomy is an effective diagnostic modality in determining a pathologic cause for splenomegaly in this patient population. Laparoscopic splenectomy can be performed safely in appropriate cases with craniocaudal splenic size having the largest influence on surgical approach.

Entities:  

Mesh:

Year:  2020        PMID: 32394013     DOI: 10.1007/s00268-020-05566-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  23 in total

1.  The diagnostic value of splenectomy in patients without a definitive preoperative diagnosis.

Authors:  Patrick T Hangge; William W Sheaffer; Matthew Neville; Nabil Wasif; Richard J Gray; Barbara A Pockaj; Chee-Chee H Stucky
Journal:  Am J Surg       Date:  2018-05-29       Impact factor: 2.565

2.  Diagnostic and therapeutic splenectomy for splenic lymphomas: analysis of the National Cancer Data Base.

Authors:  Jaleh Fallah; Adam J Olszewski
Journal:  Hematology       Date:  2019-12       Impact factor: 2.269

3.  Redefining the role of splenectomy in patients with idiopathic splenomegaly.

Authors:  Biju Pottakkat; Rajesh Kashyap; Ashok Kumar; Sadiq S Sikora; Rajan Saxena; Vinay K Kapoor
Journal:  ANZ J Surg       Date:  2006-08       Impact factor: 1.872

4.  'Non-tropical idiopathic splenomegaly' ('primary hypersplenism'): a review of ten cases and their relationship to malignant lymphomas.

Authors:  J V Dacie; M C Brain; C V Harrison; S M Lewis; S M Worlledge
Journal:  Br J Haematol       Date:  1969-10       Impact factor: 6.998

Review 5.  Splenectomy for immune thrombocytopenia: down but not out.

Authors:  Shruti Chaturvedi; Donald M Arnold; Keith R McCrae
Journal:  Blood       Date:  2018-01-02       Impact factor: 22.113

6.  Splenectomy in patients with undiagnosed splenomegaly.

Authors:  C C Cronin; M P Brady; C Murphy; E Kenny; M J Whelton; C Hardiman
Journal:  Postgrad Med J       Date:  1994-04       Impact factor: 2.401

7.  Surgical indications in idiopathic splenomegaly.

Authors:  John Alfred Carr; Muhammad Shurafa; Vic Velanovich
Journal:  Arch Surg       Date:  2002-01

8.  Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation.

Authors:  Fabio P S Santos; Constantine S Tam; Hagop Kantarjian; Jorge Cortes; Deborah Thomas; Raphael Pollock; Srdan Verstovsek
Journal:  Leuk Lymphoma       Date:  2013-05-15

Review 9.  A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP.

Authors:  Francesco Rodeghiero
Journal:  Br J Haematol       Date:  2018-02-26       Impact factor: 6.998

10.  Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives.

Authors:  Wilma Barcellini; Bruno Fattizzo; Anna Zaninoni
Journal:  J Blood Med       Date:  2019-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.